Chia Jie Tan
Overview
Explore the profile of Chia Jie Tan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan C, Kacerek D, Kampirapawong N, Godara A, Chaiyakunapruk N
Cancer Med
. 2025 Mar;
14(5):e70585.
PMID: 40052837
Background: There is a lack of clear guidance on the appropriate next choice of therapy for patients with relapsed/refractory multiple myeloma who become refractory to daratumumab, an anti-CD38 antibody. This...
2.
Patikorn C, Patikon C, Tan C, Cho J, Khuntha S, Ha N, et al.
Value Health
. 2025 Feb;
PMID: 39922297
Objectives: This landscape analysis aimed to summarize the role of health equity in the health technology assessment (HTA) process (topic nomination, topic prioritization, assessment, appraisal, and decision making) in Asia....
3.
Chan A, Chan D, Ng D, Zheng H, Tan Q, Tan C, et al.
Integr Cancer Ther
. 2025 Jan;
24():15347354251314514.
PMID: 39840742
Introduction: As pharmacological strategies remain limited for relieving fatigue and associated cognitive symptoms, integrative modalities such as traditional Chinese medicine (TCM) could be explored as therapeutic strategies in cancer survivors....
4.
Syeed S, Tan C, Godara A, Gooden K, Tang D, Slaff S, et al.
Pharmacoeconomics
. 2024 Dec;
PMID: 39643805
Background: Although innovation generally provides measurable improvements in disease characteristics and patient survival, some benefits can remain unclear. This study aimed to investigate patient and healthcare provider (HCP) preferences for...
5.
Tabataba Vakili S, Haywood D, Kirk D, Abdou A, Gopalakrishnan R, Sadeghi S, et al.
JCO Clin Cancer Inform
. 2024 Dec;
8:e2400119.
PMID: 39621952
Purpose: The adoption of artificial intelligence (AI) in health care may afford new avenues for personalized and patient-centered care. This systematic review explored the role of AI in symptom monitoring...
6.
Khaing W, Tan C, Patikorn C, Techasaensiri C, Pattanaprateep O, Dhippayom T, et al.
Influenza Other Respir Viruses
. 2024 Nov;
18(11):e70039.
PMID: 39497189
Background: Respiratory syncytial virus (RSV) is an important cause of acute lower respiratory infections worldwide, including Thailand. This study aimed to assess clinical and economic burdens of RSV infections across...
7.
Kennedy S, Mekhaeil S, Zhang E, Jolfaei N, Wong H, Chan A, et al.
Ann Palliat Med
. 2024 Oct;
13(5):1281-1290.
PMID: 39390654
Breast cancer (BC) diagnoses not only present physical challenges but profoundly affect survivors' psychosocial well-being leading to sexual health challenges. This clinical practice review aimed to discuss the current literature...
8.
Zuber M, Akkala S, Li N, Veettil S, Tan C, Villa Zapata L
Cancer Med
. 2024 Sep;
13(18):e70258.
PMID: 39344587
Background: Bruton's tyrosine kinase inhibitors (BTKi) and the B-cell lymphoma 2 (BCL2) inhibitor venetoclax have significantly improved outcomes and achieved durable remission in patients with chronic lymphocytic leukemia (CLL). BTKi/venetoclax-treated...
9.
Willis C, Tan C, Chhibber A, Watanabe A, Lam C, Mehta S, et al.
Breast Cancer Res Treat
. 2024 Aug;
208(3):619-630.
PMID: 39172305
Purpose: To evaluate the prevalence and characteristics of different HER2 categories among patients with advanced breast cancer (aBC) and describe treatment patterns and outcomes of those with HER2-low disease. Methods:...
10.
Tan C, Ilham S, Willis C, Kim A, Cong Z, Brixner D, et al.
Curr Med Res Opin
. 2024 Jul;
40(9):1577-1587.
PMID: 39082096
Objective: To assess the screening efficiency of an multi-cancer early detection (MCED) test added to standard of care (SoC) screening, compared to SoC screening alone, among immunocompromised individuals, and to...